Medical News: ASH: New Combo Challenges Standard Treatment for Indolent Lymphomas - in Meeting Coverage, ASH: Hematology from MedPage Today

Links shared publicly online about this topic.

  • 1,551
    total visits

Medical News: ASH: New Combo Challenges Standard Treatment for Indolent Lymphomas - in Meeting Coverage, ASH: Hematology from MedPage Today

medpagetoday.com —

NEW ORLEANS -- Bendamustine (Treanda) could replace the so-called CHOP regimen as the optimal partner with rituximab as the standard first-line treatment for indolent and mantle cell lymphomas, resear

View full resource at medpagetoday.com

Tags: Cancer, Lymphoma, Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Rituxan, News, Medical

  • Share

Most Recently Shared on December 7, 2009 at 2:22 pm By:

drsteventucker Dr Steven Tucker

Busting our CHOP? Bendamustine + Rituxan may become standard of care in some #lymphoma http://bit.ly/4X4Udz #cancer #asco #ash

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Medical News Medical News

Advertisement